Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...
PHOENIX — An attorney for a Phoenix family is asking the nation’s high court to effectively require TV stations to use tape delay when broadcasting events that could end in violence. David Abney is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback